Active Ingredient: RIFAMPIN
Proprietary Name: RIFAMPIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065028
Product Number: 001
Approval Date: Mar 14, 2001
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information